Skip to main content

Day: February 12, 2026

Namib Minerals Commences Dewatering at Redwing Mine in Support of Restart Project

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing. The Company noted that progress to date is consistent with the planned enabling works and reflects the Company’s disciplined, safety-focused approach to restarting production at the Redwing Mine. “Dewatering at Redwing is progressing as planned and represents an important milestone...

Continue reading

Aura FAT Projects Acquisition Corp Signs Binding Letter of Intent with Dalmore for Proposed Business Combination

BRISBANE, Australia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Aura FAT Projects Acquisition Corp (“AFAR”), a special purpose acquisition company, and Dalmore Holdings Pty Ltd (“Dalmore”) have entered into a binding Letter of Intent (“LOI”) in connection with a proposed business combination. Upon completion, the combined company is expected to be publicly listed on a national securities exchange in the United States. Under the terms of the LOI, all existing Dalmore shareholders are to roll their equity into the combined company. In connection with the proposed transaction, AFAR expects to raise additional capital through a private investment in public equity (“PIPE”) financing to support the combined company’s growth objectives and future development plans. The LOI is subject to completion of due diligence and final transaction structuring,...

Continue reading

IREN Added to MSCI USA Index

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026. The MSCI USA Index measures the performance of large and mid cap segments of the U.S. equity market and represents approximately 85% of the free float-adjusted market capitalization in the US. This inclusion is expected to enhance IREN’s visibility among institutional investors and index-tracking funds. Daniel Roberts, Co-Founder and Co-CEO of IREN, commented: “Being added to the MSCI USA Index reflects the scale and liquidity we have built in the business. We believe this milestone will broaden institutional access to IREN as we continue to execute on our AI Cloud strategy.” About IREN IREN is a leading AI Cloud Service Provider, delivering...

Continue reading

U.S. Department of Commerce Increases Duties on Chinese Battery-Grade Graphite to 160%+ in Final Determinations

CHATTANOOGA, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), today acknowledged the U.S. Department of Commerce’s (“Commerce”) final determinations in the antidumping and countervailing duty investigations covering anode active materials (“AAM”) imported into the U.S. from China. The total amount of the tariffs applicable to AAM imported from China will be at least 160%, subject to a final affirmative determination by the U.S. International Trade Commission (“ITC”) that the U.S. AAM industry has been materially impeded because of Chinese AAM imports. The ITC’s final determination is expected in March 2026. HighlightsSubject to the ITC’s final determination on material impediment:An antidumping duty of 93.5% will be imposed on AAM imports from China from specified companies...

Continue reading

21shares Announces Distributions on TSOL

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Solana ETF (TSOL) for staking rewards earned from its SOL holdings.Ticker Name Distribution Ex/Record Date Payable DateTSOL 21shares Solana ETF $0.316871 per share February 13, 2026 February 17, 2026About 21shares 21shares is one of the world’s leading cryptocurrency exchange traded product (ETP) providers and offers one of the largest suites of crypto ETPs in the market. The company was founded to make cryptocurrency more accessible to investors, and to bridge the gap between traditional finance and decentralized finance. 21shares listed the world’s first physically-backed crypto ETP in 2018, building a seven-year track record...

Continue reading

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

 US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase 1 LIKMEZ® (ATI-1501) Commercial Momentum with Increased U.S. Market Adoption HALIFAX, Nova Scotia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the third quarter of its fiscal year 2026, which ended on December 31, 2025. All figures are in Canadian dollars unless otherwise stated. “During the past quarter, we made important progress in advancing multiple U.S. federal funding proposals that, if awarded, could meaningfully support our key pipeline...

Continue reading

Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks

Approval will broaden the NARCAN® Nasal Spray portfolio, and improve cost-effectiveness by increasing flexibility and distribution efficiency of this life-saving medication GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) — Today, Emergent BioSolutions (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal Spray. This approval expands the NARCAN® Nasal Spray product suite to include 6-count and 24-count multipack options, specifically designed to meet the needs of partners distributing higher volumes of naloxone. These new formats offer enhanced flexibility with the same trusted product, benefiting community programs and organizations operating large-scale, multi-site, or high-volume...

Continue reading

Q-Gold Resources Invited to BMO Global Metals, Mining & Critical Minerals Conference

• Conference to be held in Hollywood, Florida from February 22 to 25, 2026 TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it has been invited to attend the BMO Global Metals, Mining & Critical Minerals Conference. BMO Capital Markets will host its 35th annual Global Metals, Mining & Critical Minerals Conference in Hollywood, Florida on February 22 – 25. Celebrating thirty-five years this year, BMO’s Global Metals, Mining and Critical Minerals Conference brings together senior leaders, global investors, policymakers, and analysts for three days of strategic insights and industry‑defining conversations. Spanning four decades, this conference has become one of the world’s leading forums for...

Continue reading

Copper Quest Announces Securities for Debt Settlement

VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) announces that it has entered into a securities for debt settlement agreement dated February 11, 2026 (the “Agreement”) with a professional advisor of the Company. Pursuant to the Agreement, the Company has agreed to settle debt in the amount of $113,405.28 through the issuance of 872,348 units (each, a “Unit”) at a deemed price of $0.13 per Unit, whereby each Unit shall be comprised of one (1) common share in the capital of the Company (each a “Share”) and one (1) Share purchase warrant (each whole, being a “Warrant”). Each Warrant will be convertible into an additional Share (a “Warrant Share”) at an exercise price of $0.165 per Warrant Share and will expire on the date...

Continue reading

Concentrix Prices $600 Million Senior Notes Offering

NEWARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — Concentrix Corporation (the “Company”) (NASDAQ: CNXC), a global technology and services leader, today announced that it has priced a public offering of $600 million aggregate principal amount of 6.500% Senior Notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with other available funds, as necessary, to redeem or otherwise repay at or prior to maturity all or a portion of its 6.650% Senior Notes due August 2, 2026 (the “2026 Notes”), of which $800 million aggregate principal amount is outstanding as of the date hereof, and pay related fees and expenses. The Offering is expected to close on February 24, 2026, subject to customary closing conditions. BofA Securities, Inc., J.P. Morgan Securities LLC, BNP Paribas Securities Corp.,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.